Sign in to view content

What Happens to Diabetic Retinopathy Severity Scores With Less Aggressive Treatment? A Post Hoc Analysis of the RISE and RIDE Open Label Extension Study

Roger A. Goldberg, MD, MBA

Video
Published 2019

Roger A. Goldberg, MD, MBA

Diabetic Retinopathy Part I Symposium

Related

Predictive Modeling of Proliferative Diabetic Retinopathy and DME Based on Analysis of High-Value Biomarkers
Kameran Lashkari, MD, FASRS
On Demand Cases, Courses, and Papers
2019
Relationship between Change in Visual Acuity and Change in Retinal Thickness during Treatment of Diabetic Macular Edema with Anti-VEGF
Daniel F. Rosberger, MD, PhD, MPH
On Demand Cases, Courses, and Papers
2019
Faricimab in Neovascular Age-Related Macular Degeneration: Year 2 Efficacy, Safety, and Durability Results From the Phase 3 TENAYA and LUCERNE Trials
Arshad M. Khanani, MD, MA, FASRS
Updates from the Field
2022

Category: Diabetic Retinopathy

See more